CHUGAI PHARMAC.UNSP.ADR 2
Depository Receipt · US1712691039 · A12ABF (PINX)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CHUGAI PHARMAC.UNSP.ADR 2
No Price
28.04.2026 20:00
Current Prices from CHUGAI PHARMAC.UNSP.ADR 2
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 UTC |
CHGCY
|
USD
|
28.04.2026 20:00
|
24,48 USD
| 1,22 USD
+5,25 %
|
Company Profile for CHUGAI PHARMAC.UNSP.ADR 2 Depository Receipt
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
Company Data
Name CHUGAI PHARMAC.UNSP.ADR 2
Company Chugai Pharmaceutical Co., Ltd.
Website
https://www.chugai-pharm.co.jp
Primary Exchange 
Frankfurt
Frankfurt
WKN A12ABF
ISIN US1712691039
Asset Class Depository Receipt
Sector Healthcare
Industry Drug Manufacturers - General
CEO Osamu Okuda
Market Capitalization 81 Mrd.
Country Japan
Currency EUR
Employees 5,0 T
Address Nihonbashi Mitsui Tower, 103-8324 Tokyo
IPO Date 2012-08-03
Dividends from 'CHUGAI PHARMAC.UNSP.ADR 2'
| Ex-Date | Dividend per Share |
|---|---|
| 29.12.2025 | 0,41 USD |
| 30.06.2025 | 0,43 USD |
| 31.12.2024 | 0,19 USD |
| 28.06.2024 | 0,11 USD |
| 28.12.2023 | 0,13 USD |
| 29.06.2023 | 0,14 USD |
| 29.12.2022 | 0,15 USD |
| 29.06.2022 | 0,14 USD |
| 29.12.2021 | 0,19 USD |
| 28.06.2021 | 0,14 USD |
Stock Splits
| Date | Split |
|---|---|
| 06.07.2020 | 12:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | CHGCY |
| Frankfurt | CUP0.F |
More Shares
Investors who hold CHUGAI PHARMAC.UNSP.ADR 2 also have the following shares in their portfolio:
